Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Why Novartis' Shah-Mehta chose a career in pharma sales
Medical Marketing and Media
Sat, 06/3/17 - 09:16 am
Tags:
Novartis, marketing, oncology
Novartis sees gaps in cancer pipeline but is adamant it doesn’t need an I-O deal
Fierce Biotech
Thu, 06/1/17 - 09:01 am
Tags:
Novartis, cancer, immuno-oncology
Novartis' Zykadia gets 1st-line nod in ALK+ lung cancer
BioPharma Dive
Thu, 06/1/17 - 09:00 am
Tags:
Novartis, Zykadia, ALK-positive non-small cell lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Tags:
Novartis, Zykadia, Pfizer, Xalkori, Roche, Alecensa, non-small cell lung cancer
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
Tags:
ASCO, IDO inhibitors, CAR-T, PDL-1 inhibitors, Merck, Incyte, NewLink Genetics, Novartis, Juno Therapeutics, Bristol-Myers Squibb
Potential Alcon sale worries Novartis investors
Drug Delivery Business News
Tue, 05/30/17 - 10:14 am
Tags:
Novartis, Alcon, devices, M&A, eye health
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
Tags:
FDA, Roche, Ocrevus, Puma Biotechnology, neratinib, Novartis
EMA recommends 11 drugs for approval in May meeting
BioPharma Dive
Thu, 05/25/17 - 09:26 am
Tags:
EMA, Europe, Sanofi, AstraZeneca, LEO Pharma, Novartis, Pfizer
Novartis to sever 250 U.S. workers days after announcing 500 cuts in Switzerland
Fierce Pharma
Wed, 05/24/17 - 10:54 am
Tags:
Novartis, layoffs
Pfizer bows first Ibrance TV spot as Novartis revs up with rival breast cancer med Kisqali
Fierce Pharma
Wed, 05/24/17 - 10:37 am
Tags:
Pfizer, Ibrance, Novartis, breast cancer, drug ads
Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth
Endpoints
Thu, 05/18/17 - 07:56 pm
Tags:
Novartis, layoffs, R&D
Blockbuster cancer drug shows surprising promise in treating severe asthma
Stat
Thu, 05/18/17 - 12:07 am
Tags:
Gleevec, severe asthma, asthma, Novartis
The top 15 generic drugmakers by 2016 revenue
Fierce Pharma
Wed, 05/17/17 - 09:39 am
Tags:
generics, Teva Pharmaceutical, Mylan Labs, Novartis, Pfizer, Allergan
Novartis, slammed by Korean scandal, tweaks its ethics, compliance policies
Fierce Pharma
Mon, 05/15/17 - 10:37 pm
Tags:
Novartis, ethics, Korean, compliance
Novartis set to ride Entresto wave, says report
BioPharma Dive
Mon, 05/15/17 - 01:44 pm
Tags:
Novartis, Entresto
GlaxoSmithKline aims for the whole consumer-health shebang with $10.3B Novartis JV buyout
Fierce Pharma
Mon, 05/15/17 - 09:20 am
Tags:
consumer health, M&A, GSK, Novartis
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Tags:
Novartis, Durect, Sandoz, biosimilars, generics, Posimir, R&D
Novartis continues its blitz on NASH deals, grabbing an exclusive tie-up in race to develop cocktails
Endpoints
Thu, 05/4/17 - 08:02 pm
Tags:
Novartis, NASH, Conatus Pharmaceuticals, Allergan
Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it
Endpoints
Wed, 05/3/17 - 10:52 am
Tags:
Magenta Therapeutics, Novartis, stem cells, HSC835
Novartis takes the long view on CAR-T, grabbing licenses on new tech for next-gen therapies
Endpoints
Wed, 05/3/17 - 10:05 am
Tags:
Novartis, CAR-T, cell therapy, Celyad

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.